NitisinoneTreatment of Tyrosinemia Type 1 HT1
21/09/2023 Alternative Treatments
Price: Check with seller
Description
Tyrosinemia Type 1 (HT-1) is an autosomal recessive genetic condition that impairs the patient's capacity to break down the amino acid tyrosine. This causes a serious build-up of toxic byproducts, causing critical kidney and liver damage in affected patients. Luckily, Nitisinone, a promising treatment of Tyrosinemia type 1 has transformed the treatment of this genetic condition. By blocking an enzyme involved in the breakdown of tyrosine, Nitisinone scales down the accumulation of hazardous substances, preventing organ damage. When used with low-protein foods and other suitable measures, the drug Nitisinone has significantly enhanced the prognosis for patients with HT-1, offering hope and quality of life (QoL).
Comments
More Details